The European Patent Office (EPO) has published a patent application, EP2026030562A1, related to "Modified Bacteria for Reproductive Health." This publication, dated March 18, 2026, details specific International Patent Classification (IPC) codes including C12N (Microbiology, genetics and molecular biology), A61K (Preparations for medical, dental or toilet purposes), and A61P (Specific therapeutic activity of chemical compounds or medicinal preparations).

This is a patent application publication, not a final rule or enforcement action. It does not impose new compliance obligations on regulated entities. However, companies in the biotechnology and pharmaceutical sectors involved in reproductive health research and development should be aware of this publication as it pertains to intellectual property within their field. The application is designated for several European states.